Schneyer Mark C.

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 7. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 7
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
ACADIA PHARMACEUTICALS INCEVP, CHIEF FINANCIAL OFFICEROption exercisenothing paid14,292 sharesAug 7, 2026ACADIA PHARMACEUTICALS INCEVP, CHIEF FINANCIAL OFFICERnothing paidExercise · Aug 7Option exercise14,292Aug 7, 2026
ACADIA PHARMACEUTICALS INCEVP, CHIEF FINANCIAL OFFICEROption exercisenothing paid5,849 sharesAug 7, 2026ACADIA PHARMACEUTICALS INCEVP, CHIEF FINANCIAL OFFICERnothing paidExercise · Aug 7Option exercise5,849Aug 7, 2026
ACADIA PHARMACEUTICALS INCEVP, CHIEF FINANCIAL OFFICEROpen-market sell$272,6049,292 sharesAug 7, 2026ACADIA PHARMACEUTICALS INCEVP, CHIEF FINANCIAL OFFICER$272,604Sell · Aug 7Open-market sell9,292Aug 7, 2026
ACADIA PHARMACEUTICALS INCEVP, CHIEF FINANCIAL OFFICEROpen-market sell$145,0005,000 sharesAug 7, 2026ACADIA PHARMACEUTICALS INCEVP, CHIEF FINANCIAL OFFICER$145,000Sell · Aug 7Open-market sell5,000Aug 7, 2026
ACADIA PHARMACEUTICALS INCEVP, CHIEF FINANCIAL OFFICEROption exercise$254,96914,292 sharesAug 7, 2026ACADIA PHARMACEUTICALS INCEVP, CHIEF FINANCIAL OFFICER$254,969Exercise · Aug 7Option exercise14,292Aug 7, 2026